Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis

Sebastiano Gili, Walter Grosso Marra, Fabrizio D'Ascenzo, Enrica Lonni, Andrea Calcagno, Margherita Cannillo, Flavia Ballocca, Enrico Cerrato, Martina Pianelli, Umberto Barbero, Massimo Mancone, James J. DiNicolantonio, Carl J. Lavie, Pierluigi Omedè, Antonio Montefusco, Stefano Bonora, Mauro Gasparini, Giuseppe Biondi-Zoccai, Claudio Moretti, Fiorenzo Gaita
  • European Heart Journal, February 2016, European Society of Cardiology
  • DOI: 10.1093/eurheartj/ehv734

statins and HIV:

What is it about?

It is about safety and efficacy of statins in HIV patients

Why is it important?

Because: it is the first comprenesive assessment of efficacy of statins in HIV patients it compares different kind of statins, confiming safety and efficacy of statins


Dr Fabrizio D'Ascenzo

It may be a starting point for: - physician to drive information for these high risk patients - researcher for further studies

Read Publication

The following have contributed to this page: Dr Sebastiano Gili, Dr Fabrizio D'Ascenzo, and Prof. Giuseppe Biondi-Zoccai